奥马利祖马布作为一个有效的治疗激素诱导的血管在一个变性人:一个案例报告
Lorenzo Marinelli1, Giovanna Motta1, Lorenzo Castella1
1Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
Endocrine, metabolic & immune disorders drug targets
|July 14, 2025
概括
这项研究详细介绍了第一次报告的跨性别者对丸激素治疗的系统性过敏反应病例. 奥马利祖马布成功地控制了这些反应,使得持续的性别肯定激素治疗成为可能.
科学领域:
- 内分泌学 在内分泌学.
- 过敏学 过敏学
- 跨性别者健康 跨性别者健康
背景情况:
- 性别确认激素治疗对于跨性别和性别多样性个体至关重要.
- 丸激素治疗是男性化激素治疗的常见组成部分.
- 很少报告对的系统性过敏反应.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471
Antiasthma Drugs: Leukotriene Modifiers
486
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
486
Open Angle Glaucoma: Treatment
579
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
579


